Markets Stocks Economy Crypto Earnings Banking Energy
Home Stocks Feature
Stocks · Exclusive

Catapult Sports stock may finally reflect cash earnings, Jefferies says

Catapult Sports stock may finally reflect cash earnings, Jefferies says
Stocks · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Sep 8, 2026 3 min read

Catapult Sports, the Australian wearable technology company known for its athlete tracking devices, has seen its shares tumble roughly 50% over the past 12 months. But according to analysts at Jefferies, the worst of the accounting drag may be over, and the stock could finally start reflecting the cash the business actually produces.

Why the shares fell

Catapult's decline has been steep, but much of it stems from non-cash charges tied to acquisition accounting. When a company buys another business, it often records amortization of intangible assets—such as customer relationships or technology—that reduces reported earnings but does not involve actual cash leaving the company. These charges can make a profitable business look less profitable on paper.

Jefferies argues that these non-cash downgrades are now fully reflected in analysts' forecasts. In other words, the market has already priced in the accounting noise, and future earnings reports may be less distorted by these one-off items.

What this means for investors

For everyday investors, the key takeaway is that Catapult's reported earnings may soon align more closely with its cash generation. If the company's operations are healthy, the stock could start trading on the strength of its underlying business rather than on accounting adjustments.

This is a common pattern for companies that grow through acquisitions. Initially, the market focuses on the headline earnings hit from amortization, but once those charges are well understood, investors often shift their attention to cash flow and operating performance.

Jefferies' view suggests that Catapult may be at that turning point. The stock's 50% decline over the past year may have already priced in the worst of the accounting drag, leaving room for the shares to respond to actual cash earnings.

Broader market context

The news comes as global markets show mixed signals. In Asia, Japan's stocks steadied as the yen strengthened on Bank of Japan rate hike expectations, while AI chip rallies lifted South Korean and Taiwanese stocks to multi-month highs. These moves highlight how sector-specific and regional factors continue to drive investor sentiment.

For Catapult, the focus remains on its own fundamentals rather than broader market trends. The company operates in the sports technology niche, providing wearable devices and analytics to professional teams and athletes. Its products track movement, performance, and injury risk, making it a key player in the growing sports analytics market.

What to watch next

Investors will likely watch Catapult's upcoming earnings reports for signs that cash earnings are indeed improving. If the company can demonstrate that its operations generate solid cash flow, the stock may begin to recover from its year-long slump.

However, it's important to remember that a stock's price is not guaranteed to follow any single metric. Even if cash earnings are strong, other factors—such as competition, customer concentration, or broader market conditions—could still weigh on the share price.

For those considering Catapult, the Jefferies note offers a more optimistic view than the recent price action suggests. But as with any investment, it's wise to look beyond the headline numbers and understand the full picture before making decisions.

The bottom line

Catapult Sports' stock has had a rough year, but the accounting headwinds that contributed to the decline may finally be behind it. With non-cash charges now baked into forecasts, the market may start rewarding the company for the cash it actually generates. That could mark a turning point for the shares—and for investors who have been waiting for the stock to reflect the underlying business.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B